Smaller biopharma companies must do due diligence with their CMC strategy for BLA filings.
Khanh Ngo Courtney
Advertisement
Khanh Ngo Courtney, PhD, is senior director of Biologics, Avomeen.
Articles by Khanh Ngo Courtney
Advertisement
Latest Updated Articles
Selecting the Right CMC Strategy for BiologicsPublished: October 15th 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
5
